Target intelligence / Profile preview

GPN-loop GTPase 1 (GPN1)

Target
GPN1
Molecular classification
GTPase, Enzyme, Molecular chaperone (assembly factor), Other (SIMIBI class GTPase)
01

Overview

GPN-loop GTPase 1 (GPN1) is an evolutionarily conserved GTPase characterized by a signature Gly-Pro-Asn (GPN) motif, widely present in eukaryotes and archaea but not in bacteria[1][2]. GPN1 is essential for the assembly and nuclear import of the 12-subunit RNA polymerase II (Pol II) complex. It functions as a molecular chaperone, facilitating the correct assembly of RNA polymerase II by transiently binding hydrophobic peptide regions in newly synthesized polymerase subunits and promoting their proper interface formation upon GTP hydrolysis[1]. Structural studies demonstrate that GPN1 undergoes major conformational changes between its GDP- and GTP-bound states, using a "lock-switch-rock" mechanism to regulate substrate binding and release[2]. Depletion or mutation of GPN1 disrupts polymerase II biogenesis and can result in cytoplasmic accumulation of its key subunits, highlighting its essential role in basic gene expression machinery. Though dysfunctions in GPN1 have been linked to neuromuscular pathologies in humans, and its activity is vital for cell survival in yeast, it is not currently known to be the direct target of therapeutic drugs[1][2]. Note: There are currently no known drugs, mechanisms of action, biomarkers, or specific safety concerns directly associated with targeting GPN1 in the therapeutic context.

Other names
MBDINRPAP4XAB1HUSSY-23MBDinNTPBPATPBD1AMBD2-interacting proteinRNAPII-associated protein 4XPA-binding protein 1RNA polymerase II associated protein 4ATP(GTP)-binding protein
02

Biological functions

Assembly and biogenesis of RNA polymerase II complexNuclear trafficking of RNA polymerase IIMolecular chaperoning of hydrophobic protein/peptide regionsRegulation of protein complex formation and stability
03

Disease associations

Potential roles in neuromuscular diseases (e.g., myofibrillar myopathies with protein aggregation)Essential for cell viability (lethal when deleted in yeast)Other (dysfunction may affect RNA polymerase II assembly and nuclear import)

Beyond the preview

Go deeper on GPN-loop GTPase 1 (GPN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPN-loop GTPase 1 (GPN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call